Mark K. White - 20 Nov 2023 Form 4/A - Amendment Insider Report for Annovis Bio, Inc. (ANVS)

Reporting relationship: Director
Issuer ticker: ANVS
Reported as of: 20 Nov 2023
Net transaction value: +$12,139
SEC form: 4/A - Amendment
Accepted by SEC: 22 Nov 2023, 16:27:49 UTC
Original report date: 21 Nov 2023
Prior SEC filing: 03 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Henrey Hagopian III, Attorney-in-Fact for Mark K. White

Key filing fact

Mark K. White filed Form 4/A - Amendment for Annovis Bio, Inc. (ANVS) on 22 Nov 2023.

Key facts

This page summarizes Mark K. White's Form 4/A - Amendment filing for Annovis Bio, Inc. (ANVS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Nov 2023, 16:27.

Change

Previous filing in this sequence was filed on 03 Jul 2024.
Current net transaction value: +$12,139.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANVS transaction

Common Stock

Award

Transaction value: $12,139
Shares: +1,990
Change %: +3.4%
Price: $6.10
Shares after: 61,167
Date: 20 Nov 2023
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

This amendment is being filed solely to reflect the modification of the terms of the previously reported purchase on the original form 4 filed on November 21, 2023 (the "Original Form 4"), as agreed to by the registrant and the reporting person on November 22, 2023.